E-LIB Suche - Ergebnisse für: JACOBS, R. JAKE

1

Prevalence of hepatitis A virus risk factors in a very low ..:

Mohler-Kuo, Meichun ; Steffen, Robert ; Bopp, Matthias..
Vaccine. 25 (2007) 52 - p. 8718-8725 , 2007

Link: https://doi.org/10.1016/..

2

Hepatitis B Risks and Immunization Coverage Among American ..:

Connor, Bradley A. ; Jake Jacobs, R. ; Meyerhoff, Allen S.
Journal of Travel Medicine. 13 (2006) 5 - p. 273-280 , 2006

Link: https://doi.org/10.1111/..

3

Immunization Needs of Chronic Liver Disease Patients Seen i..:

Jacobs, R. Jake ; Meyerhoff, Allen S ; Saab, Sammy
Digestive Diseases and Sciences. 50 (2005) 8 - p. 1525-1531 , 2005

Link: https://doi.org/10.1007/..

4

Hepatitis A Immunization Strategies: Universal versus Targe..:

Jacobs, R. Jake ; Meyerhoff, Allen S. ; Zink, Thomas
Clinical Pediatrics. 44 (2005) 8 - p. 705-709 , 2005

Link: https://doi.org/10.1177/..

5

Cost-Effectiveness of Hepatitis A/B Vaccination in the Priv..:

JACOBS, R. JAKE ; MEYERHOFF, ALLEN S.
Sexually Transmitted Diseases. 32 (2005) 8 - p. 465 ff. , 2005

Link: https://www.jstor.org/st..

6

Cost-effectiveness of universal childhood hepatitis A vacci..:

Valenzuela, M. Teresa ; Jacobs, R. Jake ; Arteaga, Oscar...
Vaccine. 23 (2005) 32 - p. 4110-4119 , 2005

Link: https://doi.org/10.1016/..

7

Cost effectiveness of hepatitis A/B versus hepatitis B vacc..:

Jake Jacobs, R. ; Rosenthal, Philip ; Meyerhoff, Allen S.
Vaccine. 22 (2004) 9-10 - p. 1241-1248 , 2004

Link: https://doi.org/10.1016/..

8

Cost-Effectiveness of Hepatitis A/B Vaccine versus Hepatiti..:

JACOBS, R. JAKE ; MEYERHOFF, ALLEN S.
Sexually Transmitted Diseases. 30 (2003) 11 - p. 859-865 , 2003

Link: https://www.jstor.org/st..

9

Cost-Effectiveness of Hepatitis A/B Vaccine versus Hepatiti..:

Jacobs, R. Jake ; Meyerhoff, Allen S.
Sexually Transmitted Diseases. 30 (2003) 11 - p. 859-865 , 2003

Link: https://doi.org/10.1097/..

10

Impact of Long‐Acting Growth Factors on Practice Dynamics a..:

Beveridge, Roy A. ; Rifkin, Robert M. ; Moleski, Ronald J....
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 23 (2003) 12P2 - p. , 2003

Link: https://doi.org/10.1592/..

11

An economic assessment of pre-vaccination screening for hep..:

Jacobs, R.Jake ; Saab, Sammy ; Meyerhoff, Allen S.
Public Health Reports. 118 (2003) 6 - p. 550-558 , 2003

Link: https://doi.org/10.1016/..

12

Regional variation in the cost effectiveness of childhood h..:

JACOBS, R. JAKE ; GREENBERG, DAVID P. ; KOFF, RAYMOND S...
The Pediatric Infectious Disease Journal. 22 (2003) 10 - p. 904-914 , 2003

Link: https://doi.org/10.1097/..

13

Valuation of Symptomatic Hepatitis A in Adults: Estimates B..:

Jacobs, R Jake ; Moleski, Ronald J. ; Meyerhoff, Allen S.
PharmacoEconomics. 20 (2002) 11 - p. 739-747 , 2002

Link: https://doi.org/10.2165/..

14

Economic value to parents of reducing the pain and emotiona..:

MEYERHOFF, ALLEN S. ; WENIGER, BRUCE G. ; JACOBS, R. JAKE
The Pediatric Infectious Disease Journal. 20 (2001) Supplement - p. S57-S62 , 2001

Link: https://doi.org/10.1097/..

15

Comparative Cost Effectiveness of Varicella, Hepatitis A, a..:

Jacobs, R.Jake ; Meyerhoff, Allen S.
Preventive Medicine. 33 (2001) 6 - p. 639-645 , 2001

Link: https://doi.org/10.1006/..